Perspective Therapeutics (CATX) Enterprise Value (2010 - 2026)

Perspective Therapeutics recorded quarterly Enterprise Value of -$487.9 million in Q1 2026, down 237.06% quarter-over-quarter from -$144.7 million in Q4 2025, and down 28.72% year-over-year from -$684.5 million in Q1 2025.

Perspective Therapeutics' Enterprise Value history runs 17 years deep, the most recent figure standing at -$487.9 million for Q1 2026.

  • In Q1 2026, Enterprise Value fell 28.72% year-over-year to -$487.9 million; the TTM figure through Mar 2026 stood at -$487.9 million (down 28.72% YoY), while the FY2025 annual figure was -$144.7 million, up 36.22% from the prior year.
  • Enterprise Value came in at -$487.9 million for Q1 2026 at Perspective Therapeutics, down from -$144.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$9.2 million in Q4 2023 to a low of -$487.9 million in Q1 2026.
  • A 5-year average of -$167.9 million and a median of -$144.7 million in 2025 frame the typical range for Enterprise Value.
  • Across the five-year window, Enterprise Value soared 78.89% in 2023 and slumped 2356.33% in 2024, its largest moves.
  • Perspective Therapeutics' Enterprise Value stood at -$43.8 million in 2022, then jumped by 78.89% to -$9.2 million in 2023, then plunged by 2356.33% to -$226.9 million in 2024, then soared by 36.22% to -$144.7 million in 2025, then plunged by 237.06% to -$487.9 million in 2026.
  • According to Business Quant data, Enterprise Value over the past three periods registered -$487.9 million, -$144.7 million, and -$174.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -6.66 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -2.88 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -8.17 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -1.21 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -3.67 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -3.09 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -1.12 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -2.07 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -426.00 Mn
10 Perspective Therapeutics 380.23 Mn 380.23 Mn - -487.86 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -487.86 Mn
Dec 31, 2025 -144.74 Mn
Sep 30, 2025 -174.14 Mn
Jun 30, 2025 -354.33 Mn
Mar 31, 2025 -379.00 Mn
Dec 31, 2024 -226.92 Mn
Sep 30, 2024 -309.20 Mn
Jun 30, 2024 -292.87 Mn
Mar 31, 2024 -180.65 Mn
Dec 31, 2023 -9.24 Mn
Sep 30, 2023 -17.98 Mn
Jun 30, 2023 -28.32 Mn
Mar 31, 2023 -36.45 Mn
Dec 31, 2022 -43.76 Mn
Sep 30, 2022 -54.11 Mn
Jun 30, 2022 -55.89 Mn
Mar 31, 2022 -58.90 Mn
Dec 31, 2021 -60.35 Mn
Sep 30, 2021 -61.69 Mn
Jun 30, 2021 -63.83 Mn
Mar 31, 2021 -64.84 Mn
Dec 31, 2020 -9.59 Mn
Sep 30, 2020 -1.94 Mn
Jun 30, 2020 -2.39 Mn
Mar 31, 2020 -2.41 Mn
Dec 31, 2019 -3.18 Mn
Sep 30, 2019 -4.58 Mn
Jun 30, 2019 -5.33 Mn
Mar 31, 2019 -6.39 Mn
Dec 31, 2018 -7.87 Mn
Sep 30, 2018 -9.19 Mn
Jun 30, 2018 -3.43 Mn
Mar 31, 2018 -4.52 Mn
Dec 31, 2017 -5.68 Mn
Sep 30, 2017 -7.26 Mn
Jun 30, 2017 -8.97 Mn
Mar 31, 2017 -10.41 Mn
Dec 31, 2016 -11.95 Mn
Sep 30, 2016 -13.71 Mn
Jun 30, 2016 -12.39 Mn
Mar 31, 2016 -11.60 Mn
Dec 31, 2015 -12.60 Mn
Sep 30, 2015 -1.59 Mn
Jun 30, 2015 -14.59 Mn
Mar 31, 2015 -1.08 Mn
Dec 31, 2014 -1.34 Mn
Jun 30, 2014 -17.68 Mn
Mar 31, 2014 -23.70 Mn
Dec 31, 2013 -4.41 Mn
Sep 30, 2013 -5.28 Mn
Jun 30, 2013 -2.90 Mn
Mar 31, 2013 -3.68 Mn
Dec 31, 2012 -4.44 Mn
Sep 30, 2012 -5.03 Mn
Jun 30, 2012 -2.67 Mn
Mar 31, 2012 -2.52 Mn
Dec 31, 2011 -3.44 Mn
Sep 30, 2011 -1.59 Mn
Jun 30, 2011 -2.11 Mn
Mar 31, 2011 -3.48 Mn
Dec 31, 2010 -2.77 Mn
Sep 30, 2010 -1.02 Mn